Matrix metalloproteinases in cancer: Prognostic markers and therapeutic targetsPia Vihinen, Veli‐Matti Kähäri|International Journal of Cancer|2002Cited by 637
European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromesRobert Knobler, Thomas Krieg, Ulrike Just et al.|Journal of the European Academy of Dermatology and Venereology|2017Cited by 261
Smad3 Mediates Transforming Growth Factor-β-induced Collagenase-3 (Matrix Metalloproteinase-13) Expression in Human Gingival FibroblastsSuvi‐Katri Leivonen, Veli‐Matti Kähäri|Journal of Biological Chemistry|2002Cited by 102
Complement Component C3 and Complement Factor B Promote Growth of Cutaneous Squamous Cell CarcinomaPilvi Riihilä, Veli‐Matti Kähäri|American Journal Of Pathology|2017Cited by 94
Serpin Peptidase Inhibitor Clade A Member 1 (SerpinA1) Is a Novel Biomarker for Progression of Cutaneous Squamous Cell CarcinomaMehdi Farshchian, Veli‐Matti Kähäri|American Journal Of Pathology|2011Cited by 90